Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Steve Pemberton, Bryan Greene, Mark McDonough, Richard Hockett, Judd Jessup

Premium

Rheonix has named Steven Pemberton as its vice president of sales and marketing and Bryan Greene as its director of consumable manufacturing.

Pemberton formerly held leadership posts at Abbott Diagnostics, Ventana Medical Systems, and Roche Diagnostics while Greene previously was responsible for design transfer and product manufacturing at Life Technologies.

Ithaca, NY-based Rheonix markets its Hi-Fi SNP microarray platform for biomarker discovery and test development (BAN 12/20/2011).


CombiMatrix has elected its Chief Commercial Officer Mark McDonough and its Chief Medical Officer Richard Hockett to serve on its board of directors.

McDonough, who joined CombiMatrix last August from Pathwork Diagnostics, will take over as CEO later this week when current CEO Judd Jessup retires.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.